Critical role of Nrf2 in oxidative stress‐induced retinal ganglion cell death
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
NF‐E2 related factor 2 (Nrf2) is a key transcription factor that plays a pivotal role in endogenous protection against oxidative stress. However, the role of Nrf2 in visual disorders remains unclear. It has been reported that oxidative stress is thought of as one of the causes of glaucoma. Here, we investigate whether the function of Nrf2 in oxidative stress‐induced retinal ganglion cell (RGC) death. This study used adult male Nrf2 deficient mice (Nrf2 KO) and age‐ and sex‐matched wild‐type (WT) mice. We dissociated and purified N‐4‐[4‐didecylaminostryryl]‐N‐methyl‐pyridinium iodide‐labeled RGC s with fluorescence‐activated cell sorting, and tried to detect the Nrf2 and Keap1 genes. In the absence of nerve crush (NC), the number of RGC s in Nrf2 KO mice was almost same as that in WT mice. 1‐(2‐cyano‐3‐, 12‐dioxooleana‐1, 9 (11)‐dien‐28‐oyl) imidazole (CDDO‐Im), an Nrf2 activator, prevented NC‐induced loss of RGC s in WT mice. Seven days after NC, without treatment, the number of RGC s in Nrf2 KO mice was significantly lower than in WT mice. In addition, after CDDO‐Im treatment, quantitative RT‐PCR showed increased expression of antioxidant and phase II detoxifying enzymes. These results suggest that up‐regulation of Nrf2 signaling after CDDO‐Im treatment may be a novel therapeutic strategy for the protection of RGC s, especially in glaucoma. image This study suggests that NF‐E2 related factor 2 (Nrf2), a transcription factor, plays a pivotal role in counteracting oxidative stress. Most importantly, a neuroprotective effect against oxidative stress‐induced retinal ganglion cell (RGC) death was achieved with the pharmacological Nrf2 activator CDDO‐Im. This suggests that pharmacological treatment to up‐regulate Nrf2 signaling may be a new therapeutic technique to protect RGCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060 · cited 2×
“Therefore, NC should be a good model for the investigation of NTG. Nrf2 has shown strong potential to protect against a broad range of diseases associated with oxidative stress (Clements et al. 2006; Padmanabhan et al. 2006; Satoh et al. 2006; Singh et al. 2006).”
BackgroundClements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · cited 2×
“Therefore, NC should be a good model for the investigation of NTG. Nrf2 has shown strong potential to protect against a broad range of diseases associated with oxidative stress (Clements et al. 2006; Padmanabhan et al. 2006; Satoh et al. 2006; Singh et al. 2006).”
BackgroundSelf-citationEnomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
Yücel, Y. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00026-0 · Cited by 384
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297 · cited 1×
“In Nrf2 knockout (Nrf2 KO) mice, induction of antioxidant response elements-dependent cytoprotective genes is severely impaired, making them susceptible to a variety of pharmacological and environmental toxicants (Aoki et al. 2001; Enomoto et al. 2001; Osburn and Kensler 2008; Uno et al. 2010).”
BackgroundSelf-citationLiby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4539 · Cited by 283 · cited 2×
“We also tested whether enhancing Nrf2 signaling with the extremely potent synthetic triterpenoid activator 1-(2- cyano-3,12-dioxooleana-1,9(11)-dien-28-pyl)imidazole (CDDO-Im) (Liby et al. 2005), protects against oxidative stress-induced RGC death.”
BackgroundShih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273
Cited by
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage
Xiong, W., MacColl Garfinkel, A. E., Li, Y., Benowitz, L. I., & Cepko, C. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79735 · Cited by 280
Ocular Blood Flow and Influencing Factors for Glaucoma
Nakazawa, T. (2016) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000183 · Cited by 129
Self-citationGlaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne, N. N., Núñez-Álvarez, C., Joglar, B., & del Olmo-Aguado, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.032 · Cited by 101
The concept of gene therapy for glaucoma: the dream that has not come true yet
Sulak, R., Liu, X., & Smedowski, A. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.375319 · Cited by 40
“Since the oxidative stress is one of the common mechanisms of neurodegeneration (Himori et al., 2013; Lin and Kuang, 2014; Naguib et al., 2021; Sanz-Morello et al., 2021), the enhancement of antioxidants and antioxidant enzymes has become a target of interest in 96 |NEURAL REGENERATION RESEARCH|Vol…”
Background
Metadata
- Authors
- Himori, N., Yamamoto, K., Maruyama, K., Ryu, M., Taguchi, K., Yamamoto, M., & Nakazawa, T.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2013-06-17
- Volume
- 127
- Issue
- 5
- Pages
- 669-680
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1981976464
- Cited by
- 132
- References
- 12
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.